article · SPORT TK-Revista EuroAmericana de Ciencias del Deporte
Chronic lung diseases (CLDs) in children, such as asthma, cystic fibrosis, and bronchopulmonary dysplasia, significantly impact respiratory function and overall quality of life. Exercise-based pulmonary rehabilitation (PR) has emerged as a multidisciplinary approach to improving lung function, exercise capacity, and reducing hospitalization rates. This study assessed the effectiveness of a structured PR program in pediatric patients with CLDs in Damietta Governorate, Egypt. A randomized controlled trial was conducted with 400 pediatric patients with CLDs (aged 6–16 years) divided equally into intervention and control groups. The intervention group underwent a 12-week exercise-based PR program incorporating respiratory training, airway clearance techniques, and physical therapy, while children in the control group received standard medical care consisting of routine follow-ups, medication management, and lifestyle counseling without structured rehabilitation exercises. Post-intervention results demonstrated significant improvements in forced expiratory volume (FEV1), forced vital capacity (FVC), peak expiratory flow, six-minute walk test (6MWT), and quality of life scores (p < 0.001). Additionally, hospitalization frequency and medication dependency were significantly reduced (p < 0.001). The findings reveal that exercise-based PR significantly improves pulmonary function, exercise tolerance, and overall quality of life in children with chronic lung diseases. Additionally, PR effectively reduces hospitalization rates and medication dependency, offering a sustainable approach to disease management.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.6018/sportk.682631
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.